Mintz represented CXL Ophthalmics (CXLO) on the deal while Foley & Lardner LLP represented AXA IM Alts.CXL Ophthalmics (CXLO), a clinical-stage company developing a minimally-invasive treatment…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
